{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14(1)"],"submitter":["Di Staso R"],"funding":["Università di Bologna (University of Bologna)"],"journal":["Blood cancer journal"],"pagination":["197"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11544145"],"repository":["biostudies-literature"],"pubmed_title":["Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma."],"pmcid":["PMC11544145"],"funding_grant_id":["ALMAIDEA2022CUP:J33C22001420001"],"pubmed_authors":["Casadei B","Iacoboni G","Locke FL","Bailen R","Houot R","Voorhees TJ","Di Staso R","Mian A","Terol MJ","Masetti R","Hill B","Argnani L","Kittai AS","Reguera-Ortega JL","Gori D","Broccoli A","Bachy E","Morschhauser F","Martin Garcia-Sancho A","Le Gouill S","Bastos-Oreiro M","Kwon M","Jain M","Gutierrez A","Mead M","Thieblemont C","Maranzano MJ","Barba P","Zinzani PL"],"additional_accession":[]},"is_claimable":false,"name":"Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma.","description":null,"dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2025-04-04T02:09:29.757Z","creation":"2025-04-04T02:09:29.757Z"},"accession":"S-EPMC11544145","cross_references":{"pubmed":["39511146"],"doi":["10.1038/s41408-024-01183-8"]}}